Radiotherapy plus adjuvant goserelin improves survival in men with poor prognosis prostate cancer: Abstracted from: Pilepich MV, Winter K, Lawton CA, et al. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma: long-term results of Phase III RTOG 85-31. Int J Radiat Oncol Biol Phys 2005; 61:1285–90.

✍ Scribed by Mack Roach III

• Book ID: 116394989
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 86 KB
• Volume: 31
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2005.08.002